Literature DB >> 29388084

Unexplained cough: it is time to rule out Sjogren's syndrome.

Matthew Koslow1,2,3, Shaye Kivity4, Vicktoria Vishnevskia-Dai5, Issahar Ben-Dov6,7.   

Abstract

Sjogren's syndrome is associated with chronic cough, but sicca symptoms are missing from cough evaluation guidelines. We evaluated patients with unexplained cough for undiagnosed Sjogren's syndrome. Patients referred to our pulmonary clinic (Sheba Medical Center, 2009 to 2012) with unexplained cough and concomitant dry eyes were selected for evaluation. Unexplained cough was defined as chronic cough of unknown etiology despite algorithm-based evaluation and treatment. Patients were evaluated in a dedicated clinic by a pulmonologist, rheumatologist, and ophthalmologist specializing in autoimmune disease. Patients completed the Leicester Cough Questionnaire, spirometry, antibody testing for anti Ro/La, ophthalmologic examination with visual acuity, eyelid, ocular surface fluorescein staining, tear break-up time and Schirmer's test, full slit lamp, and fundus examinations. Four-year follow-up was conducted by telephone questionnaire. We identified 24 patients among which 22 (21 females) agreed for evaluation. Eight patients (36%), seven initially, and one during follow-up were diagnosed with Sjogren's syndrome (SS) (six secondary and two primary SS). At 4-year follow-up, cough tended to persist and improve in only 37% with SS. These include 2 (Scl and RA) who received rituximab and 1 (stage 1 sarcoidosis) with spontaneous improvement. In contrast, cough improved in most (64%) patients without SS; the majority (eight/nine) report intensified disease-specific treatment (five allergic and three GERD). We describe patients in whom unexplained chronic cough was associated with dry eyes. Focused workup revealed undiagnosed Sjogren's syndrome in 36%. Dry eyes, with or without SS, is under-recognized and should be added to diagnostic algorithms for unexplained cough.

Entities:  

Keywords:  Ophthalmology; Salivary glands; Sjogren’s syndrome; Xerotrachea

Mesh:

Year:  2018        PMID: 29388084     DOI: 10.1007/s10067-018-3987-4

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  41 in total

1.  Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999.

Authors:  R O Crapo; R Casaburi; A L Coates; P L Enright; J L Hankinson; C G Irvin; N R MacIntyre; R T McKay; J S Wanger; S D Anderson; D W Cockcroft; J E Fish; P J Sterk
Journal:  Am J Respir Crit Care Med       Date:  2000-01       Impact factor: 21.405

Review 2.  Clinical manifestations and early diagnosis of Sjögren syndrome.

Authors:  Stuart S Kassan; Haralampos M Moutsopoulos
Journal:  Arch Intern Med       Date:  2004-06-28

Review 3.  The diagnosis and management of chronic cough.

Authors:  A H Morice; G A Fontana; A R A Sovijarvi; M Pistolesi; K F Chung; J Widdicombe; F O'Connell; P Geppetti; L Gronke; J De Jongste; M Belvisi; P Dicpinigaitis; A Fischer; L McGarvey; W J Fokkens; J Kastelik
Journal:  Eur Respir J       Date:  2004-09       Impact factor: 16.671

4.  The Leicester Cough Questionnaire.

Authors:  Nathan Ward
Journal:  J Physiother       Date:  2015-08-29       Impact factor: 7.000

5.  Alveolitis correlates with clinical pulmonary involvement in primary Sjögren's syndrome.

Authors:  Y A Dalavanga; S H Constantopoulos; V Galanopoulou; L Zerva; H M Moutsopoulos
Journal:  Chest       Date:  1991-06       Impact factor: 9.410

Review 6.  Therapeutic Strategies to Treat Dry Eye in an Aging Population.

Authors:  Nisreen S Ezuddin; Karam A Alawa; Anat Galor
Journal:  Drugs Aging       Date:  2015-07       Impact factor: 3.923

7.  Muc5b is required for airway defence.

Authors:  Michelle G Roy; Alessandra Livraghi-Butrico; Ashley A Fletcher; Melissa M McElwee; Scott E Evans; Ryan M Boerner; Samantha N Alexander; Lindsey K Bellinghausen; Alfred S Song; Youlia M Petrova; Michael J Tuvim; Roberto Adachi; Irlanda Romo; Andrea S Bordt; M Gabriela Bowden; Joseph H Sisson; Prescott G Woodruff; David J Thornton; Karine Rousseau; Maria M De la Garza; Seyed J Moghaddam; Harry Karmouty-Quintana; Michael R Blackburn; Scott M Drouin; C William Davis; Kristy A Terrell; Barbara R Grubb; Wanda K O'Neal; Sonia C Flores; Adela Cota-Gomez; Catherine A Lozupone; Jody M Donnelly; Alan M Watson; Corinne E Hennessy; Rebecca C Keith; Ivana V Yang; Lea Barthel; Peter M Henson; William J Janssen; David A Schwartz; Richard C Boucher; Burton F Dickey; Christopher M Evans
Journal:  Nature       Date:  2013-12-08       Impact factor: 49.962

8.  Bronchial inflammation, respiratory symptoms and lung function in Primary Sjögren's syndrome.

Authors:  Jesús Bellido-Casado; Vicente Plaza; César Díaz; Carme Geli; José Domínguez; Gisela Margarit; Montserrat Torrejón; Jordi Giner
Journal:  Arch Bronconeumol       Date:  2011-03-22       Impact factor: 4.872

Review 9.  An empiric integrative approach to the management of cough: ACCP evidence-based clinical practice guidelines.

Authors:  Melvin R Pratter; Christopher E Brightling; Louis Philippe Boulet; Richard S Irwin
Journal:  Chest       Date:  2006-01       Impact factor: 9.410

Review 10.  Rituximab-induced lung disease: A systematic literature review.

Authors:  H Lioté; F Lioté; B Séroussi; C Mayaud; J Cadranel
Journal:  Eur Respir J       Date:  2009-07-16       Impact factor: 16.671

View more
  1 in total

1.  Consensus Guidelines for Evaluation and Management of Pulmonary Disease in Sjögren's.

Authors:  Augustine S Lee; R Hal Scofield; Katherine Morland Hammitt; Nishant Gupta; Donald E Thomas; Teng Moua; Kamonpun Ussavarungsi; E William St Clair; Richard Meehan; Kieron Dunleavy; Matt Makara; Steven E Carsons; Nancy L Carteron
Journal:  Chest       Date:  2020-10-16       Impact factor: 9.410

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.